Conference report: Omnipod® 5 tubeless automated insulin delivery system improves clinical outcomes in type 1 diabetes

Data in adults & adolescents (n=128) showed significant increase in time in range from 65% to 74%, or an additional 2.2hrs/day, & overall reduction HbA1c from 7.16% to 6.78%. Corresponding data for children (n=112) were 53% to 68% (3.7 hrs/day) and HbA1c from 7.67% to 6.99%.

Source:

Biospace Inc.